Bismuthum Subnitricum 6c label

Bismuthum Subnitricum 6c

Bismuthum Subnitricum 6c Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

If pregnant or breast feeding ask a health professional before use.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Severe vomiting due to obstruction

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Bismuthum Subnitricum 6c Manufacturers

  • Paramesh Banerji Life Sciences Llc
    Bismuthum Subnitricum 6c | American Health Packaging
    No Recall

    Bismuthum Subnitricum 6c | American Health Packaging

    Bismuthum Subnitricum 6c | American Health Packaging
    2.1 Dosage in Adults

    Use the lowest effective dose for the patient. The recommended initial dose is 5 mg for women and either 5 or 10 mg for men, taken only once per night immediately before bedtime with at least 7 to 8 hours remaining before the planned time of awakening. If the 5 mg dose is not effective, the dose can be increased to 10 mg. In some patients, the higher morning blood levels following use of the 10 mg dose increase the risk of next day impairment of driving and other activities that require full alertness [see WARNINGS AND PRECAUTIONS (5.1)]. The total dose of zolpidem tartrate tablets should not exceed 10 mg once daily immediately before bedtime.

    The recommended initial doses for women and men are different because zolpidem clearance is lower in women.

    2.2 Special Populations

    Elderly or debilitated patients may be especially sensitive to the effects of zolpidem tartrate. Patients with hepatic insufficiency do not clear the drug as rapidly as normal subjects. The recommended dose of zolpidem tartrate tablets in both of these patient populations is 5 mg once daily immediately before bedtime [see WARNINGS AND PRECAUTIONS (5.1); USE IN SPECIFIC POPULATIONS (8.5)].

    2.3 Use with CNS Depressants

    Dosage adjustment may be necessary when zolpidem tartrate tablets are combined with other CNS depressant drugs because of the potentially additive effects [see WARNINGS AND PRECAUTIONS (5.1)].

    2.4 Administration

    The effect of zolpidem tartrate tablets may be slowed by ingestion with or immediately after a meal.